Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Pharmaceutical agents that impede the initiation and progression of primary and secondary DMS disruptions

Pharmaceutical agents that impede the initiation and progression of primary and secondary DMS disruptions

US Patent 6130221 · Granted Oct 10, 2000

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Radiotherapeutic and companion imaging agents to target MC1R2025
Focal treatment of prostate cancer2025
Delta-opioid receptor targeted agent for molecular imaging and immunotherapy of 2025
Melanocortin 1 receptor ligands and methods of use2024
Method of enhancing the therapeutic efficacy of fexapotide triflutate in treatin2024
Bacteriophage-based vaccines and engineered bacteriophage2023
Methods of reducing the need for surgery in patients suffering from benign prost2023
Molecular imaging of cancer cells in vivo2022
Toll-like receptor 2 ligands and methods of making and using thereof2022
Radiotherapeutic and companion imaging agents to target MC1R2022
Fibrous nerve conduit for promoting nerve regeneration2022
Coated, antimicrobial, chemically strengthened glass and method of making2022